NCT00583037

Brief Summary

Neurally Adjusted Ventilatory Assist (NAVA) is a new mode of mechanical ventilation that is controlled by the electrical activity of the diaphragm (EAdi). The EAdi is a signal that represents the patient's breathing effort, and hence with NAVA, the assist being delivered is synchronized and proportional to the demands of the patient. This is a prospective physiological study of the feasibility of NAVA ventilation over 24 hours. The aim is to demonstrate that NAVA can maintain spontaneous breathing and unload the respiratory muscles during both sleep and wake cycles over a 24 hour period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2006

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2006

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

December 20, 2007

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 31, 2007

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2008

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
Last Updated

June 1, 2009

Status Verified

May 1, 2009

Enrollment Period

1.7 years

First QC Date

December 20, 2007

Last Update Submit

May 29, 2009

Conditions

Keywords

Neurally Adjusted Ventilatory AssistSleep qualityAdultCritical Care

Outcome Measures

Primary Outcomes (1)

  • Feasibility of NAVA as assessed by: • Assessment of FiO2 changes • Assessment of the NAVA catheter function: o Stability of the EAdi signal from NAVA catheter o Requirements for NAVA catheter position change • Reasons for ventilator alarms

    24 hours

Secondary Outcomes (1)

  • Patient tolerance of NAVA as assessed by: • Changes in SAS scoring and sedation requirement • Changes in vital signs (HR/BP) and vasopressors requirements • Changes in oxygenation/ventilation

    24 hours

Study Arms (1)

NAVA

EXPERIMENTAL

Implementation of NAVA for 24 hours

Device: Neurally Adjusted Ventilatory Assist (NAVA)

Interventions

Mechanical ventilation controlled by diaphragm electrical activity

Also known as: Servo i Ventilator System- NAVA Catheters (6671277, 6671280, 6671282, 6671287, 6671290), Servo i Ventilator System- NAVA HW option (6671957), Servo i Ventilator System- NAVA SW option (6671965)
NAVA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to the ICU will be screened on a daily basis for the presence of the following characteristics:
  • Adult (\>18 years old) intubated and mechanically ventilated patients with evidence of spontaneous breathing defined as:
  • Patient is on pressure support ventilation OR
  • Patient is on pressure control ventilation with the ability to trigger 50% of the breaths.
  • Sedation Agitation Score (SAS) score greater than or equal to 2
  • Presence of an arterial line
  • Patients meeting these criteria will be considered eligible for recruitment into the study

You may not qualify if:

  • Next of kin unavailable
  • Patient/next of kin refuses informed consent.
  • Attending physician refuses to allow enrollment
  • Pregnancy
  • Any contraindication to insertion of a nasogastric tube including, but not limited to: severe oropharyngeal malformation or bleeding, esophageal varices, tumor, infection, stenosis, or rupture
  • Hemophilia or other severe bleeding disorder
  • Presence or suspicion of central/brain stem neurologic disorder/severe neuromuscular disease
  • Treatment with neuromuscular blockers
  • History of heart and/or lung transplantation
  • Mean arterial blood pressure \< 60 mm Hg with or without vasopressors or inotropes
  • Any contraindication to reducing sedation to obtain a targeted SAS score of 3 (e.g. anticipated hemodynamic instability after reduction of sedation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St-Michael's Hospital

Toronto, Ontario, M5B1W8, Canada

Location

Related Publications (5)

  • Sinderby C, Navalesi P, Beck J, Skrobik Y, Comtois N, Friberg S, Gottfried SB, Lindstrom L. Neural control of mechanical ventilation in respiratory failure. Nat Med. 1999 Dec;5(12):1433-6. doi: 10.1038/71012. No abstract available.

    PMID: 10581089BACKGROUND
  • Sinderby C. Ventilatory assist driven by patient demand. Am J Respir Crit Care Med. 2003 Oct 1;168(7):729-30. doi: 10.1164/rccm.2307004. No abstract available.

    PMID: 14522808BACKGROUND
  • Beck J, Brander L, Slutsky AS, Reilly MC, Dunn MS, Sinderby C. Non-invasive neurally adjusted ventilatory assist in rabbits with acute lung injury. Intensive Care Med. 2008 Feb;34(2):316-23. doi: 10.1007/s00134-007-0882-x. Epub 2007 Oct 25.

    PMID: 17960364BACKGROUND
  • Beck J, Campoccia F, Allo JC, Brander L, Brunet F, Slutsky AS, Sinderby C. Improved synchrony and respiratory unloading by neurally adjusted ventilatory assist (NAVA) in lung-injured rabbits. Pediatr Res. 2007 Mar;61(3):289-94. doi: 10.1203/01.pdr.0000257324.22406.93.

    PMID: 17314685BACKGROUND
  • Allo JC, Beck JC, Brander L, Brunet F, Slutsky AS, Sinderby CA. Influence of neurally adjusted ventilatory assist and positive end-expiratory pressure on breathing pattern in rabbits with acute lung injury. Crit Care Med. 2006 Dec;34(12):2997-3004. doi: 10.1097/01.CCM.0000242520.50665.9F.

    PMID: 16957635BACKGROUND

MeSH Terms

Conditions

Respiratory AspirationRespiratory InsufficiencySleep Initiation and Maintenance Disorders

Interventions

Interactive Ventilatory Support

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Fabrice Brunet, MD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR
  • Christer Sinderby, PhD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 20, 2007

First Posted

December 31, 2007

Study Start

May 1, 2006

Primary Completion

January 1, 2008

Study Completion

May 1, 2008

Last Updated

June 1, 2009

Record last verified: 2009-05

Locations